Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2022 Sep 19;119(39):e2209267119. doi: 10.1073/pnas.2209267119

Functional determination of calcium-binding sites required for the activation of inositol 1,4,5-trisphosphate receptors

Vikas Arige a,1, Lara E Terry a,1, Larry E Wagner II a,1, Sundeep Malik a, Mariah R Baker b, Guizhen Fan b, Suresh K Joseph c, Irina I Serysheva b,2, David I Yule a,2
PMCID: PMC9522344  PMID: 36122240

Significance

The inositol 1,4,5-trisphosphate receptor (IP3R) Ca2+ release channel is a key component of the Ca2+ signaling cellular machinery. Regulation of IP3R activity is fundamental for defining the spatiotemporal characteristics of Ca2+ signals important for the appropriate activation of effectors. The most important regulator of IP3R activity is an increase in [Ca2+] itself, which initially activates and then, at higher concentrations, inhibits channel activity. While the residues in IP3R important for IP3 binding are established, the motifs that coordinate Ca2+ have not been functionally determined. Based on predictions from recently published cryo-EM structures of IP3Rs, we used imaging techniques and electrophysiology to experimentally define the identity of the evolutionarily well-conserved residues in IP3Rs essential for Ca2+ binding and channel activation.

Keywords: inositol 1,4,5 triphosphate receptor; calcium signaling; ion channel regulation

Abstract

Inositol 1,4,5-trisphosphate receptors (IP3Rs) initiate a diverse array of physiological responses by carefully orchestrating intracellular calcium (Ca2+) signals in response to various external cues. Notably, IP3R channel activity is determined by several obligatory factors, including IP3, Ca2+, and ATP. The critical basic amino acid residues in the N-terminal IP3-binding core (IBC) region that facilitate IP3 binding are well characterized. In contrast, the residues conferring regulation by Ca2+ have yet to be ascertained. Using comparative structural analysis of Ca2+-binding sites identified in two main families of intracellular Ca2+-release channels, ryanodine receptors (RyRs) and IP3Rs, we identified putative acidic residues coordinating Ca2+ in the cytosolic calcium sensor region in IP3Rs. We determined the consequences of substituting putative Ca2+ binding, acidic residues in IP3R family members. We show that the agonist-induced Ca2+ release, single-channel open probability (P0), and Ca2+ sensitivities are markedly altered when the negative charge on the conserved acidic side chain residues is neutralized. Remarkably, neutralizing the negatively charged side chain on two of the residues individually in the putative Ca2+-binding pocket shifted the Ca2+ required to activate IP3R to higher concentrations, indicating that these residues likely are a component of the Ca2+ activation site in IP3R. Taken together, our findings indicate that Ca2+ binding to a well-conserved activation site is a common underlying mechanism resulting in increased channel activity shared by IP3Rs and RyRs.


An increase in the intracellular calcium concentration ([Ca2+]i) is essential for innumerable fundamental biological processes. Following stimulation, the concerted action of a diverse array of proteins, collectively termed the Ca2+ signaling “toolkit,” functions to increase and sequester Ca2+ to precisely define the spatiotemporal characteristics of Ca2+ signals necessary to control diverse physiological endpoints with specificity and fidelity (1, 2). As a function of exquisite regulation of their activity by a multitude of diverse modulatory inputs, the inositol 1,4,5-trisphosphate receptor family (IP3R) of Ca2+ release channels are a central component of this cellular machinery. In vertebrates, there are three genes that code for IP3R, ITPR1–3, which result in three distinct IP3R subtypes: IP3R type 1 (IP3R1), IP3R type 2 (IP3R2), and IP3R type 3 (IP3R3), which share approximately 60 to 70% amino acid sequence identity (37). IP3Rs are ubiquitously expressed and predominantly localized to the endoplasmic reticulum (ER) membrane, where functionally they are assembled as either homo- or heterotetramers. While binding of IP3, generated as a result of the activation of phospholipase C is necessary to gate the channel, it is also clear that the binding of Ca2+ itself is obligatory to activate the receptor (8). Thus, IP3 and Ca2+ are considered coagonists of IP3R (9).

Early work using truncated IP3R1 established that the N-terminal 788 amino acid residues were required to bind IP3. Subsequently, mutagenesis approaches established the minimal IP3-binding core (IBC, residues 224 to 557) and identified the positively charged residues required for coordinating the phosphate moieties in IP3 (10). More recent X-ray crystallography of the isolated IBC domains (11, 12) and single-particle cryoelectron microscopy (cryo-EM) studies (1316) have revealed the conserved three-dimensional architecture of the ligand-binding domains (LBDs) that includes β-trefoil domains (β-TF1) (residues 1 to 225) and βTF2 (residues 226 to 435), and a helical armadillo repeat, ARM1 domain (residues 436 to 665), providing structural determinants for the coordination of IP3 and adenophostin A, a structural mimetic of IP3, in the IP3-binding pocket. These studies showed that ligand binding is accompanied by conformational changes in the LBDs (11, 12, 14, 15) and also involves global conformational changes in the cytoplasmic scaffold connected to the channel pore (14, 15). Critically, the functional relevance of these residues has also been confirmed by mutagenesis (17). Indeed, one of the residues (R269) important for IP3 binding is the locus of a point mutation (R269W) that results in spino-cerebellar ataxia in patients as a result of a poorly functional IP3R1 (18). Furthermore, the mutagenesis of these residues, in increasing numbers of IP3R monomers within a concatenated tetramer, has led to the demonstration that IP3 binding to all four subunits in an IP3R tetramer is an absolute prerequisite for channel opening (19).

Extensive functional characterization at the level of Ca2+ release and at the single-channel level have demonstrated that Ca2+ modulates IP3R channel opening in a complex manner (8, 2025). In the presence of IP3, low concentrations of Ca2+ (<300 nM) facilitate channel opening; however, at higher concentrations, Ca2+ promotes channel closure to result in a bell-shaped regulation of IP3R activity (8). These data are consistent with Ca2+ interacting at two distinct sites, one that results in activation and a further site that attenuates activity (26). Models of this regulation have postulated that IP3 binding modulates the affinity of the Ca2+-binding sites for Ca2+ to favor increased or decreased IP3R channel activity (24, 2730). This control of IP3R activity by the interplay between coagonists is widely considered to mechanistically underlie the hierarchy of Ca2+ signaling events observed in cells, including localized Ca2+ blips, Ca2+ puffs, propagating Ca2+ waves, and Ca2+ oscillations (21, 3133).

While the determinants of IP3 binding are firmly established (10), elucidating the motifs that coordinate Ca2+ in IP3R have proved elusive and have yet to be functionally determined (34). Notably, using gel overlay assays, several linear fragments of IP3R across various domains were shown to bind 45Ca2+ (35, 36). Nevertheless, point mutations at conserved acidic amino acids in regions identified in the IBC were without any effect on Ca2+-dependent activation of IP3R, ruling out the possibility of Ca2+-binding site(s) in this domain (37). A further series of studies proposed glutamate (E) 2101 (Fig. 1B) as a key residue in IP3R for activation by Ca2+. Mutating this residue diminished Ca2+ sensitivity for activation of IP3R1 several-fold, but it also altered the IP3R sensitivity to inhibition by Ca2+ (38, 39). Nevertheless, there is little structural evidence supporting direct binding of this residue to Ca2+, indicating that this site perhaps has an allosteric role in stabilizing a confirmation favoring Ca2+ binding to bona fide Ca2+-binding site(s) (21, 27).

Fig. 1.

Fig. 1.

Structural and sequence conservation of the Ca2+-binding site across IP3R and RyR families of Ca2+ release channels. (A) Two opposite subunits in the rat IP3R1 are color-coded by domains and overlaid with cryo-EM density. (B) Structural alignment of IP3R1 Ca2+-binding sensor domain (indicated with dashed line in (A); PDB ID: 8EAQ; EMDB: EMD-27982 in (45) with IP3R3 (tan, PDB ID: 6UQK) and RyR1 (gray, PDB ID: 5T15) Ca2+-binding pockets with identical residues labeled. The equivalent human residues in IP3R1 that form the Ca2+ binding pocket are hE1938/rE1978, hE2002/rE2042, hT2614/rT2657, and hE2109/rE2101. (C) Sequence alignment for the Ca2+-sensor region across all three IP3R and RyR subtypes. The conserved E1938, E2002, and T2614 residues in IP3R1 are highlighted in green.

Perhaps the best clues to potential Ca2+-binding sites in IP3R come from structural studies of the ryanodine receptor (RyR) (3840). IP3Rs share structural and functional features with RyRs; both are intracellular Ca2+ release channels with tetrameric architecture and are regulated in a biphasic manner by Ca2+ (8). The cryo-EM structure of RyR determined in the presence and absence of its activating ligands (Ca2+/adenosine triphosphate [ATP]/caffeine) revealed several regions that coordinate Ca2+ ions in RyRs. These include paired EF-hand domains in the central region of RyR and a pocket of negatively charged residues in the core solenoid and C-terminal domain (40). While mutation of the EF hands did not alter Ca2+ activation of RyR2, mutation of the putative binding pocket in RyR1/2 altered Ca2+-dependent activation of RyRs (41, 42). Of note, an analogous Ca2+-binding site is present in the juxta membrane domain of IP3R between the third armadillo repeat (ARM3) and linker (LNK) domains and is conserved in IP3Rs across species and through IP3R subtypes (43). Two cryo-EM studies of human IP3R3 in the presence of IP3 and Ca2+ have suggested two Ca2+-binding sites, including a site within the putative Ca2+ sensor regions located at the interface between the ARM3 (residues 1,587 to 2,119) and LNK (residues 2,538 to 2,608) domains (15, 44). The first structure (15, 44) was solved in supra-physiological [Ca2+], but the limited resolution of the reconstruction precludes the identification of any structural determinants within the Ca2+-binding pockets. Moreover, the channel pore was not engaged under the aforementioned conditions; therefore, it is unclear whether either site relates to stimulation or inhibition of the channel. A second recent human IP3R3 (hIP3R3) structure solved at 3.6 Å resolution under more physiological [Ca2+] reported a Ca2+ density in the putative Ca2+ sensor region in two structures extracted from the same cryo-EM dataset (44). In one of their reported structures, the ion conduction pore was dilated to allow the passage of Ca2+. However, the functional role of this Ca2+ binding site remains to be elucidated.

In this study, based on our single-particle cryo-EM structure of IP3R1 determined at ∼3.26 Å resolution (45), in which a clear interaction between Ca2+ and the putative Ca2+ sensor region is documented, we performed a series of experiments to examine the consequences of substituting putative Ca2+ binding-conserved residues in IP3R subtypes. We generated stable cell lines expressing wild-type (WT) IP3Rs and compared agonist-evoked Ca2+ release, Ca2+ puffs, and single-channel properties with their counterparts harboring substitutions at putative Ca2+ coordinating sites. Neutralizing the negative charge on side chain residues at these conserved Ca2+ coordinating residues decimated both Ca2+ release and Ca2+ puff activity evoked by IP3-generating agonists. Remarkably, substitution with a smaller but similarly charged residue markedly diminished agonist-induced Ca2+ release and Ca2+ puffs compared to their WT counterparts. Of note, comparison of single-channel properties revealed that the Ca2+ sensitivity was dramatically right shifted by charge neutralization, indicating that this site is likely the Ca2+ activation site. In contrast, retaining charge on the side chain residue had little effect on Ca2+ sensitivity; however, open probability of channel was significantly diminished. Overall, our investigations demonstrate a critical role for the negative charge on side chains of conserved Ca2+ coordinating residues in IP3Rs for electrostatic interactions with Ca2+ to facilitate channel opening and subsequent activation of agonist-induced Ca2+ release.

Results

Identification of Putative Ca2+ Coordinating Residues in IP3Rs.

Our high-resolution cryo-EM structures of rat IP3R1 (rIP3R1) in physiologically relevant Ca2+-bound states in the presence or absence of IP3 and ATP clearly identifies Ca2+ bound in the putative Ca2+ sensor site formed by E1978, E2042 (in the ARM3 domain, chartreuse), and T2657 residue (in the LNK domain, orange), corresponding to E1938, E2002, and T2614 in the human sequence (Fig. 1A), respectively (45). A comparative structural alignment strongly indicates that a putative Ca2+ sensor site in rIP3R1 is analogous to the Ca2+-binding pockets in IP3R3 (tan, PDB ID: 6DR2) and RyR1 (gray, PDB ID: 5T15) (Fig. 1B). Moreover, the three aforementioned residues constituting the putative Ca2+ sensor site in human IP3R1 (hIP3R1) are well conserved across all hIP3R (15) and RyR subtypes (40, 41, 43) (Fig. 1C). Strikingly, these residues are also highly conserved in the evolution of IP3R and RyR proteins across various organisms (SI Appendix, Fig. S1A). In contrast, the putative Ca2+-binding pocket located between the α-helical domain (HD) and the ARM2 in hIP3R3 (15) is not conserved between RyRs and IP3Rs (SI Appendix, Fig. S1B). In addition, we could not detect any Ca2+ densities in this region in our cryo-EM structure of IP3R1 (45). These observations indicate that conserved residues forming the Ca2+-binding site in the two main families of intracellular Ca2+-release channels are good candidates to mediate the regulation of IP3R by Ca2+.

Substitutions at the Putative Ca2+ Coordinating Residues in hIP3R1 Diminished Agonist-Induced Ca2+ Release.

IP3R1 is the best-studied subtype in terms of regulation by Ca2+ (13, 46, 47). Therefore, we stably overexpressed WT hIP3R1 or hIP3R1 with substitutions at the 2002 glutamic acid (E) residue (Fig. 1C) to aspartate (D), alanine (A), or glutamine (Q) in HEK-3KO cells previously generated in our laboratory by CRISPR-Cas9 technology to lack native IP3Rs (19). The rationale for the substitutions chosen being that the E-D residue change retained the side chain charge; the E-Q substitution resulted in a similar-size side chain that does not preserve the side chain charge but is still hydrophilic; and the E-A substitution maintains the β carbon moiety but has no other side chain chemistry.

When expressed in HEK-3KO cells, IP3R1 protein levels of exogenously (exo) expressed WT hIP3R1, hIP3R1 E2002D, hIP3R1 E2002A, and hIP3R1 E2002Q stable cell lines were higher than WT HEK293 and endogenous (endo) hIP3R1 cells previously generated in our laboratory by CRISPR-Cas9 technology to lack the other two native IP3Rs (19) (Fig. 2 A and B). When stably expressed, all of the mutants were properly targeted to the ER, exhibiting a characteristic reticular expression pattern (SI Appendix, Fig. S2A). In addition, each mutant receptor ran exclusively as a tetramer on native nondenaturing gels (SI Appendix, Fig. S2B). To investigate the functional consequences of these substitutions on hIP3R1 channel activity, we performed single-cell imaging assays to assess IP3-induced Ca2+ release using carbachol (CCh) and trypsin as agonists acting via the Gαq-coupled M3 muscarinic receptor and protease-activated receptor 2, respectively. CCh-induced Ca2+ release was markedly diminished in the hIP3R1 E2002D cells when compared to exo hIP3R1 cells at lower doses of CCh (3, 10 µM); however, such differences disappeared at a higher dose of CCh (30 µM), presumably due to the recruitment of additional IP3Rs caused by Ca2+-induced Ca2+ release at higher concentrations of CCh (Fig. 2 C and D). CCh-induced Ca2+ release was significantly attenuated in hIP3R1 E2002A and hIP3R1 E2002Q cells as compared to exo and endo hIP3R1 cells at all doses of CCh (3, 10, and 30 µM) (Fig. 2 C and D). Moreover, the percentage of responding cells was also significantly lower in stable cells with substitutions at the E2002 residue compared to WT cells (SI Appendix, Fig. S3A). Similarly, trypsin-evoked Ca2+ release was also significantly attenuated in cells with substitutions at the E2002 site when compared to both endo and exo hIP3R1 cells (SI Appendix, Fig. S3 C and D). The HEK-3KO cells, as previously demonstrated, failed to respond to stimulation with either trypsin (SI Appendix, Fig. S3 C and D) (18, 19) or CCh (Fig. 2 CE). Furthermore, in a population-based assay performed on a FlexStation3 plate reader with microfluidics, CCh-induced Ca2+ release as reflected by both the maximum amplitude changes (Fig. 2E) and area under the curve (AUC) (SI Appendix, Fig. S3B) were markedly attenuated in E2002D and decimated in E2002A and E2002Q cells when compared to both exo and endo IP3R1 cells. These results suggest that the negative charge on the side chain residue at the 2002 position in hIP3R1 is critical for binding to Ca2+, and neutralizing this charge prevented IP3-induced Ca2+ release and IP3R1 activation.

Fig. 2.

Fig. 2.

Substituting E2002 with D, A, or Q residue in hIP3R1 significantly diminished agonist-induced Ca2+ signals when stably expressed in HEK-3KO cells. Stable hIP3R1 cell lines with a substitution at E2002 position to D, A, or Q were generated in HEK-3KO cells. (A) A representative western blot depicting IP3R1 and GAPDH protein levels in WT HEK293 (Wt), HEK-3KO (3KO), HEK-2KO (lacking native IP3R2 and IP3R3 subtypes, endo hIP3R1), 3KO cells overexpressing WT IP3R1 (exo hIP3R1), and E2002D/A/Q substitution (hR1 E2002D/A/Q). (B) Scatterplot depicting quantification of IP3R1 protein level normalized to GAPDH from three independent western blots. Data are means ± SDs of three (n = 3) independent experiments. ##P < 0.01, ###P < 0.001 when compared to endo hIP3R1 cell line and *P < 0.05 when compared to exo hIP3R1 cell line; one-way ANOVA with Tukey’s test was performed. (C) Representative traces showing CCh-induced (3, 10, and 30 µM) Ca2+ release from 3KO (orange), WT (blue), endo hIP3R1 (green), exo hIP3R1 (cyan), hIP3R1 E2002D (red), hIP3R1 E2002A (purple), and hIP3R1 E2002Q (black) cells in single-cell assays. (D) Scatterplot summarizing change in amplitude (peak ratio – basal ratio: average of 20 ratio points immediately preceding addition) to increasing doses of CCh (3, 10, and 30 µM) for experiments similar to those shown in (C). Data are means ± SDs of at least three independent experiments. ##P < 0.01, ####P < 0.0001 when compared to endo hIP3R1 cell line and ***P < 0.001, ****P < 0.0001 when compared to exo hIP3R1 cell line; Mann-Whitney U test was performed. ns: not significant. (E) Dose-response curve showing maximum amplitude from Fura-2/AM loaded 3KO (orange), endo hIP3R1 (green), exo hIP3R1 (cyan), hIP3R1 E2002D (red), hIP3R1 E2002A (purple), and hIP3R1 E2002Q (black) cells in population-based assays when treated with increasing concentrations (100 nM, 300 nM, 1 μM, 3 μM, 10 μM, 30 μM, and 100 μM) of CCh. (F) Representative traces of Cal-520 fluorescence ratios (ΔF/F0) from the center of a single puff site (∼1 × 1 µm) evoked by photolysis of ci-IP3 at 2 s (indicated by arrow) in exo hIP3R1 (upper trace) and hIP3R1 E2002D (lower trace) cells using a TIRF microscope. (G) TIRFM images from exo hIP3R1 (Upper panel) and hIP3R1 E2002D (Lower panel) showing Ca2+ puffs at indicated time point. Typical of at least 10 independent experiments. Arrows indicate Ca2+ puffs/puff sites, and asterisks indicate globalization of Ca2+ signals. (H) Scatterplots summarizing number of puffs/cell, puff sites/cell, and % globalization in exo hIP3R1 cells (cyan), hIP3R1 E2002D (red), hIP3R1 E2002A (purple), and hIP3R1 E2002Q (black) cells (n = 10 cells). Data are means ± SDs of 10 (n = 10) independent experiments. ****P < 0.0001 when compared to exo hIP3R1 cell line; Mann-Whitney U test was performed. Unless otherwise stated, all of the data above comes from at least n = 3 experiments.

Next, to measure the activity of the hIP3R more directly and without the global effects on neighboring IP3R by increasing Ca2+, we investigated the effect of substitutions at the E2002 site on the fundamental Ca2+ signals mediated by IP3Rs (called Ca2+ puffs) upon uncaging caged inositol triphosphate (ci-IP3) using total internal reflection microscopy (TIRFM) (31, 33, 4850). As shown in the representative traces (Fig. 2F) and images (Fig. 2G), the number of fundamental Ca2+ signals obtained from the hIP3R1 E2002D cells were significantly diminished when compared to WT exo hIP3R1 cells following the uncaging of ci-IP3 (Movies S1 and S2). The number of puffs per cell, puff sites per cell, and the percentage of cells in which Ca2+ signals globalized were significantly attenuated in hIP3R1 E2002D cells as compared to WT hIP3R1 cells (Fig. 2H). The rise and fall times did not differ between these two cells (SI Appendix, Fig. S3E). We failed to detect any puffs in cells expressing hIP3R1 with either E2002A or E2002Q, again reinforcing the importance of the negative charge at this residue in the Ca2+ activation site (Fig. 2H).

Substituting the Putative Ca2+ Coordinating Residue in hIP3R3 Diminished Agonist-Induced Ca2+ Release.

Given that this residue is identical in all human IP3R subtypes, we postulated that if E2002 indeed represented an important charged residue for the coordination of Ca2+ and subsequent activity of hIP3R1, then the functional effect of mutating this residue should be conserved in other hIP3R subtypes. Therefore, we generated stable cell lines in HEK-3KO with substitution at the analogous E1946 residue in hIP3R3 (Fig. 1C). The IP3R3 protein levels of the hIP3R3 E1946Q stable cell line were slightly more than the WT HEK293 and endogenous hIP3R3 cells previously generated in our laboratory by CRISPR-Cas9 technology to lack the other two native IP3Rs (Fig. 3 A and B). When stably expressed, hIP3R3 E1946Q was properly targeted to the ER, exhibiting a characteristic reticular expression pattern (SI Appendix, Fig. S4A). In addition, the mutant receptor, like hIP3R3, ran exclusively as a tetramer on native nondenaturing gels (SI Appendix, Fig. S4B). To determine the functional consequence of this substitution, as before, we performed single-cell imaging assays to assess IP3-induced Ca2+ release using CCh and trypsin as agonists. While the exo hIP3R3, endo hIP3R3 and WT HEK293 cells responded to agonist stimulation, the hIP3R3 E1946Q cells, like 3KO cells, did not respond to various doses of CCh (3, 10, and 30 µM) (Fig. 3 C and D). The percentage of responding cells were also significantly lower in stable cells with the E1946Q substitution as compared to WT cells (SI Appendix, Fig. S5A).

Fig. 3.

Fig. 3.

Substituting E1946 with Q residue in hIP3R3 significantly diminished agonist-induced Ca2+ release when stably expressed in HEK-3KO cells. Stable hIP3R3 cells with substitution at the E1946 position to Q were generated in HEK-3KO cells. (A) A representative western blot depicting IP3R3 and GAPDH protein levels in HEK293 (Wt), HEK-3KO (3KO), HEK-2KO (lacking native IP3R1 and IP3R2 subtypes, endo hIP3R3), 3KO cells overexpressing WT hIP3R3 (exo hIP3R3), and 3KO cells overexpressing hIP3R3 with E1946Q substitution (hIP3R3 E1946Q). (B) Scatterplot depicting quantification of IP3R3 protein level normalized to GAPDH from three independent western blots. Data are means ± SDs of three (n = 3) independent experiments. ###P < 0.001 when compared to endo hIP3R3 cell line and ***P < 0.001 when compared to exo hIP3R3 cell line; one-way ANOVA with Tukey’s test was performed. (C) Representative traces showing CCh-induced (3, 10, and 30 µM) Ca2+ release from 3KO (orange), Wt (blue), endo hIP3R3 (green), exo hIP3R3 (cyan), and hIP3R3 E1946Q (red) cells in single-cell assays. (D) Scatterplot summarizing change in amplitude (peak ratio – basal ratio: average of 20 ratio points immediately preceding addition) to increasing doses of CCh for experiments similar to those shown in (C). WT and 3KO data from Fig. 2D is shown for comparison. Data are means ± SDs of three (n = 3) independent experiments. #P < 0.05, ####P < 0.0001 when compared to endo hIP3R3 cell line and ****P < 0.0001 when compared to exo hIP3R3 cell line; Mann-Whitney U test was performed. (E) Dose-response curve showing change in maximum amplitude from Fura-2/AM loaded 3KO (orange), endo hIP3R3 (green), exo hIP3R3 (cyan), and hIP3R3 E1946Q (red) cells in population-based assays when treated with increasing concentrations (100 nM, 300 nM, 1 μM, 3 μM, 10 μM, 30 μM, and 100 μM) of CCh. Unless otherwise stated, all of the data above comes from at least n = 3 experiments.

To further substantiate these results, we performed single-cell imaging experiments using trypsin (500 nM) as an agonist. A consistent lack of trypsin-induced Ca2+ release in hIP3R3 E1946Q cells was observed when compared to WT stable cells (SI Appendix, Fig. S5 C and D). Interestingly, both the WT and endo hIP3R3 cells, which express IP3R3 protein levels comparable to those of hIP3R3 E1946Q cells, responded to trypsin (SI Appendix, Fig. S5 C and D) and various doses of CCh (Fig. 3 C and D). Furthermore, we also performed population-based assays to determine CCh-induced Ca2+ release in hIP3R3 E1946Q cells. Similar to single-cell imaging assays, CCh-induced Ca2+ release, as represented by the maximum amplitude changes (Fig. 3E) and AUC (SI Appendix, Fig. S5B), was abolished in hIP3R3 E1946Q cells when compared to both exo and endo hIP3R3 cells. Overall, these results indicate that the negative charge on the conserved side chain residues in both the hIP3R1 and hIP3R3 subtypes is critical for coordinating Ca2+ and the activity of hIP3R subtypes.

Is the negative charge on the conserved side chain residues in IP3R3 essential for Ca2+ binding and activity across species? To address this question, we next generated stable cell lines expressing rat IP3R3 (rIP3R3) WT or rIP3R3 with E1945Q substitution in HEK-3KO cells (SI Appendix, Fig. S6 A and B). We performed single-cell imaging and population-based assays to determine agonist-induced Ca2+ release using these stable cells. Remarkably, both the CCh- (SI Appendix, Fig. S6 CE) and trypsin-induced (SI Appendix, Fig. S6 H and I) Ca2+ release was decreased in rIP3R3 E1945Q cells as compared to rIP3R3 WT cells. A similar decrease in CCh-induced Ca2+ release was observed in population-based assays (SI Appendix, Fig. S6 F and G). To summarize, these observations indicate that the negative charge on the conserved side chain residues in IP3Rs across multiple organisms is critical for binding to Ca2+ and the ensuing agonist-induced Ca2+ release.

Loss of Negative Charge in the Putative Ca2+-Binding Pocket Shifts the Ca2+ Sensitivity for Activation of hIP3R1.

The previous experiments suggest strongly that negatively charged residues in a putative Ca2+-binding pocket centered around E2002 are necessary for the full activity of hIP3R, but they do not provide biophysical, mechanistic insight into how Ca2+ binding controls IP3R activity. We therefore generated stable cell lines expressing WT hIP3R1 or hIP3R1 with substitutions at the E2002 and E1938 residues in DT40-3KO chicken lymphocytes, IP3R null cells (SI Appendix, Fig. S7 A and B). Interestingly, consistent with HEK-3KO cells, neutralizing the negative charge on side chain of either of these residues significantly abrogated Ca2+ signals evoked by trypsin in population-based assays in DT40 cells (SI Appendix, Fig. S7 C and D).

Next, we performed “on-nucleus” single-channel recordings of IP3R1 activity after exposure to IP3 and various [Ca2+]. As described previously, by our laboratory (5153) and others (24, 54), at an optimum [ATP] (5 mM) and at a saturating [IP3] (10 μM), the open probability (Po) of the hIP3R increased with increasing [Ca2+]; channel activity was barely evident at 10 nm Ca2+ and increased to reach a maximum Po of ∼0.7 at 200 nM Ca2+. Increasing [IP3] to 100 μM, failed to augment activity further. At higher [Ca2+], hIP3R1 activity decreased and was essentially absent at 100 μM Ca2+ (Fig. 4 A and G). Similar experiments were then performed in cells expressing hIP3R1 harboring the conservative charge mutation E2002D. While single-channel activity was reduced in cells expressing this mutation (maximal Po ∼0.45 at 200 nM Ca2+), a similar dependency on Ca2+ for activation and inhibition compared to WT hIP3R1 was retained by this mutation. The decrease in overall channel activity was not due to a reduction in the sensitivity to IP3, as increasing IP3 to 100 μM had no further effect on hIP3R1 Po (Fig. 4 B and G).

Fig. 4.

Fig. 4.

Importance of negative charges in Ca2+ sensor site for regulation of hIP3R1 by Ca2+. The activity of WT hIP3R1 and mutants was monitored in the “on-nucleus” configuration in DT40-3KO cells stably expressing the indicated constructs as detailed in Materials and Methods. (A) Representative sweeps are shown at the indicated [Ca2+] stimulated by 10 μM IP3 (unless stated otherwise) in the presence of optimal ATP for WT hIP3R1. Maximal activity is observed at 200 nM−1 μM Ca2+ and then subsequently decreases. Maximal Po was not increased by increasing [IP3] to 100 μM. (B) Representative activity is shown for E2002D hIP3R1. The maximal Po at each [Ca2+] is reduced compared with WT hIP3R1, but the regulation by increasing Ca2+ mirrors that seen with WT hIP3R1. (C) Representative activity is shown for E2002A hIP3R1. Maximal Po is markedly reduced and the [Ca2+] where maximum activity is observed is right shifted to higher [Ca2+]. Inhibition of IP3R activity occurs at similar [Ca2+] to WT hIP3R1. (D) Representative activity is shown for E1938D hIP3R1. In a fashion similar to that of E2002D, the maximal Po at each [Ca2+] is reduced compared with WT hIP3R1, but the regulation by increasing Ca2+ mirrors that seen with WT hIP3R1. (E) Representative activity is shown for E1938A hIP3R1. In a fashion similar to that of E2002A, maximal Po is markedly reduced and the [Ca2+] where maximum activity is observed is right shifted to higher [Ca2+]. Inhibition of IP3R activity occurs at similar [Ca2+] to WT hIP3R1. (F) Current versus voltage relationship for the WT (Exo hR1) and mutant hIP3R1 channels generated at 10 mM and optimal [Ca2+] for each construct. (G) Pooled data. Solid symbols: recordings obtained using 10 µM IP3 at indicated Ca2+ concentrations from Exo hR1 (Exo hIP3R1: cyan), hE2002D (red), hE1938D (green), hE2002A (purple), and hE1938A (pink). Open symbols: recordings obtained using 100 µM IP3 at an optimal Ca2+ concentration (200 nM). Inset shows pooled data for alanine mutations with an expanded y axis.

Next, we investigated the consequences of substitution of E2002 to alanine. Strikingly, no IP3R activity was evident at [Ca2+] in a range that resulted in enhanced Po in WT hIP3R1 (10 to 200 nM Ca2+). IP3R activity, albeit reduced in comparison to the hIP3R1 retaining negative charge at this residue, was observed at 1 μM, which was further enhanced by increasing [Ca2+] to 3 μM and then subsequently reduced as [Ca2+] was increased further (Fig. 4 C and G). Again, increasing the [IP3] to 100 μM failed to increase overall activity at optimum [Ca2+] for this mutation. The decreased sensitivity to activation by Ca2+ can be readily observed in the pooled data presented in Fig. 4G and insert. Notably, the [Ca2+] required for the inhibition of activity was largely unaltered by this substitution. We failed to record any single-channel activity when E2002 was mutated to glutamine. Importantly, the current-voltage relationship for each mutant was essentially identical, indicating that the single-channel conductance of each mutant was unchanged (Fig. 4F).

As previously reported, the IP3R1 exhibits modal gating; increased activity is associated with increased bursting activity (51). An increase in Ca2+ flux is not associated with a change in open or closed times within the burst, but an increase in the duration of bursts (SI Appendix, Fig. S8 AC). We observed that fundamental gating characteristics were not altered in any of the mutations. An increase in [Ca2+] both increased the burst length and concomitantly decreased the interburst interval. These data indicate that an increase in IP3R1 activity by Ca2+ is primarily associated with a destabilization of a long-closed state, while the attenuation of IP3R1 activity by Ca2+ is associated with a transition to and stabilization of this long-closed state (SI Appendix, Fig. S8 CG).

We also generated DT40-3KO cell lines stably expressing similar mutations at E1938 (SI Appendix, Fig. S7 A and B), which is predicted to be an additional negatively charged residue essential for coordinating Ca2+ in the Ca2+-sensing site (Fig. 1). In a fashion similar to that of mutations in E2002, conservation of charge by the substitution of E1938 for D in hIP3R1 resulted in a decrease in the maximum overall channel activity, with no change in the absolute sensitivity to IP3, but the relationship for activation and inhibition of channel activity by Ca2+ was retained; a maximal Po was attained at 200 nm Ca2+, which subsequently decreased at a [Ca2+] >1 μM (Fig. 4 D and G). IP3R1 activity in cells expressing hIP3R1 E1938A again displayed a right-shifted, decreased sensitivity to Ca2+, similar to E2002A, with maximum activity observed at 3 μM Ca2+ before subsequently decreasing (Fig. 4 E and G). Similar to E2002D, the inhibition of activity characteristic of higher [Ca2+] was largely unaltered when compared to WT hIP3R1. In total, these data are consistent with E2002 and E1938 comprising key Ca2+-binding residues responsible for the activation phase of the bell-shaped Ca2+ relationship underlying IP3R activity.

Discussion

The regulation of IP3R induced Ca2+ release by Ca2+ was recognized early. Initial studies reported that IP3-induced Ca2+ release from the ER was inhibited by Ca2+ (55, 56). Subsequently, a series of seminal studies reported that increasing [Ca2+] first positively potentiates IP3R activity and then at higher concentrations reduces channel activity, resulting in the characteristic bell-shaped regulation of IP3-induced Ca2+ release and channel activity, which is thought to be pivotally important for the spatiotemporal control of Ca2+ release (8, 20, 22, 24, 5760). Ongoing studies have since investigated whether this fundamental regulation is directly through the interaction with motifs in the IP3R protein itself, or through an accessory protein. For example, single-channel experiments in which [Ca2+] can be rigorously controlled on both faces of the channel indicate that IP3R activity appears to be regulated by changes in [Ca2+]i close to the open channel pore, as opposed to the [Ca2+] in the ER lumen (29).These data make it improbable that potential Ca2+ binding site(s) on the luminal face of IP3Rs contribute to activation. Moreover, the failure to detect any interactions between Ca2+-binding proteins and IP3Rs as a function of changes in the [Ca2+] makes it unlikely that Ca2+ sensitivity is conferred through an interaction with a binding partner (61). Taken together, these findings strongly indicate that the Ca2+ binding site(s) lie within the receptor.

In terms of known Ca2+-binding motifs, IP3Rs lack a canonical EF hand, C2 domain, or other conventional Ca2+-binding motifs (27); however, Ca2+ binds to several linear fragments spread across various domains (35, 36). Of note, rIP3R1 (residues 1,961 to 2,219) and rIP3R2 (residues 1,914 to 2,173) coupling domain fragments expressed as recombinant proteins in bacteria are strongly bound to 45Ca2+ (61). Nevertheless, residues coordinating Ca2+ in the IP3R that are responsible for modulating activity have not been functionally described. Recently, by comparing cryo-EM structures of RyR obtained in the presence and absence of its activating ligands (Ca2+/ATP/caffeine), putative amino acids residues forming the Ca2+-activating site were identified (40). Moreover, mutational analysis experimentally confirmed that these residues confer Ca2+ sensitivity to the RyR channel (41). Cryo-EM structures of RyR resolved in the presence of Ca2+ revealed that the pore remained open, consequently permitting the flow of Ca2+ ions from the ER to the cytoplasm (40). As noted, the key residues forming the putative Ca2+ sensor site in IP3R1 (45), hIP3R2 and hIP3R3, are perfectly conserved and similar to the Ca2+-activating site identified in human RyRs (Fig. 1). Moreover, Ca2+-binding residues at this activating site in RyR and IP3Rs are identical in a number of species representing mammals, fish, and birds and also highly conserved in some lower order organisms (Fig. 1 and SI Appendix, Fig. S1A). This conservation, together with our mutagenesis in IP3R subtypes from two species, makes it highly likely that this Ca2+ sensor region represents the Ca2+ activation site in at least all mammalian IP3R and RyR subtypes. Nevertheless, even though these residues are evolutionarily well conserved, IP3Rs in Capsaspora owczarzaki, paradoxically, appears not to be regulated by Ca2+ in a manner similar to mammalian IP3R (62) and thus, this may indicate that other structural elements required for allosteric regulation of activity by Ca2+ are absent in this species. Interestingly, in Drosophila melanogaster, a point mutation (wc703, G2117E; G2123 in variant used in SI Appendix, Fig S1A) in the calcium sensor region of IP3R caused an increase in the Ca2+-binding affinity/sensitivity and open probability of the channel (63, 64). The glutamate residue in this gain-of-function mutation may stabilize Ca2+ coordination in the Ca2+-activating site, thereby augmenting the Ca2+ sensitivity of IP3R. In the hIP3R3 structure, the HD/ARM2 putative Ca2+ binding site was poorly resolved (15). This site, while conserved in IP3R subtypes, is not present in RyRs (SI Appendix, Fig. S1B), and we could not detect any Ca2+ densities at this site in our cryo-EM structures (45). Any role for the site in the regulation of IP3R activity should be the subject of further investigation.

In the present study, based on striking similarities between RyRs and IP3Rs structures at the putative Ca2+ sensor site, we generated several stable cell lines in HEK-3KO and DT40-3KO cells (lacking all three native IP3Rs) expressing hIP3R1, hIP3R3, and rIP3R3 with substitutions at conserved amino acid residues forming the Ca2+ sensor site (Figs. 2 and 3 and SI Appendix, Figs. S6 and S7). We then interrogated the channel properties of these mutants when compared to their WT counterparts. A common concern associated with taking a mutagenesis approach to studying structure-function relationships is that mutations may grossly alter the structure of the protein in a manner unrelated to the targeted disruption. While this cannot be unequivocally ruled out without a high-resolution structure of each mutant, the observation that the mutants formed tetrameric structures that were properly localized to the ER argues against a major disruption in the protein structure (SI Appendix, Figs. S2 and S4). This idea is further reinforced by data demonstrating that the single-channel conductance (Fig. 4F) and gating characteristics of the mutants (SI Appendix, Fig. S8), indicative of the structure of the pore and the ability of conformational changes in the protein to open the pore, were identical to WT IP3R. Agonist-induced Ca2+ release was significantly reduced when the glutamic acid residue at position 2002 in hIP3R1 was substituted for the native aspartate residue (Fig. 2 and SI Appendix, Fig. S3) at this position, indicating that disruption of the structure of the putative binding pocket following reduction in the size of the residue, without altering charge, disrupted Ca2+ regulation of IP3R activity. Furthermore, agonist-induced Ca2+ release was completely abrogated upon neutralizing the negative charge on the glutamic acid side chain residue at the 2002 position by substitution with either glutamine or alanine (Fig. 2 and SI Appendix, Fig. S3), indicating that the negative charge of this residue is pivotal for activity. Similar data were obtained in DT40 cells upon neutralizing negative charge on side chain residue at either E2002 or E1938 residue in hIP3R1 (SI Appendix, Fig. S7).

Recent technological advances, using high-speed TIRFM, allow near-electrophysiological measurement of the biophysical characteristics of fundamental Ca2+ signals arising from a cluster of IP3Rs called Ca2+ puffs (31, 48, 6568). Consistent with the effect on global Ca2+ signals, Ca2+ puffs were also significantly diminished in E2002D cells or completely abrogated in E2002A and E2002Q cells (Fig. 2 FH). Notably, while diminished in number, Ca2+ puffs in cells expressing E2002D retained the kinetics of WT IP3R1 consistent with this mutant retaining its bell-shaped modulation by Ca2+ (Fig. 4G). Similarly, the substitution of glutamine for glutamic acid at the analogous 1946 position in hIP3R3 also decimated agonist-induced Ca2+ release (Fig. 3 and SI Appendix, Fig. S5). A similar result was obtained upon mutating the analogous residue in rIP3R3 (SI Appendix, Fig. S6). We did not consider substitution of multiple Ca2+ coordinating residues in a site to avoid excessive perturbations in the native structure of IP3Rs.

Our single-channel data provide unparalleled mechanistic insight into how the binding of Ca2+ to the Ca2+ sensor site influences the activity of the IP3R. Mutation of either E2002 or E1938 by substitution with an aspartate acid residue (Fig. B and D) or an alanine residue (Fig. 4 C and E) did not alter the single-channel conductance (Fig. 4F) or the modal gating of the channel in bursts (SI Appendix, Fig. S8). Notably, however, mutation of these residues with either substitution had marked effects on channel Po, and, most strikingly, the loss of negative charge markedly altered the activation of channel activity by Ca2+ without altering the inhibition at higher [Ca2+] (Fig. 4 AE). This is most clearly appreciated by comparing the pooled activity relationships for WT hIP3R1 with the charge-conserved aspartic acid substitutions at either site with the mutations to alanine (Fig. 4G). Clearly, while the activity of the aspartic acid (Fig. 4 B and D)–substituted mutants are reduced compared to WT hIP3R1 (Fig. 4A), the activity is regulated with an identical bell-shaped relationship (Fig. 4G). In contrast, the alanine mutants have further reduced maximum activity, but peak activation is achieved at higher [Ca2+] when compared to WT or glutamic acid–harboring mutants (Fig. 4 C and E). The reduction in overall activity of each mutant compared to WT is consistent with disruption of the overall integrity of the Ca2+-binding pocket by alteration in the size and charge of side chains resulting in disordered transduction of conformational changes in Ca2+ binding to gating of the pore. Primarily, these data further reinforce that the negative charge on both amino acid residues E2002 and E1938 are critically important for coordinating Ca2+ in the Ca2+ sensor site, which leads to the activation of IP3R.

Given that each protomer contributes one Ca2+ binding site in the tetrameric IP3R assembly, a remaining important question relates to the stoichiometry of Ca2+ binding necessary for activation. Ca2+ activation of IP3R single-channel activity is generally reported to be modestly positively cooperative (21), which may suggest that binding of more than a single Ca2+ activates the channel. We envision that a concatenated receptor approach with increasing numbers of subunits harboring Ca2+ binding site mutants will be used to elucidate how many Ca2+ are necessary to open the channel (19). In addition, as IP3R subtypes are differentially modulated by IP3, ATP, and activation by Ca2+ and overall activity is determined by the interplay between these regulatory inputs (21, 25, 52, 53, 69), whether the effects of Ca2+ binding are distinct in the context of particular IP3R subtypes or heterotetrametric assemblies should be determined. Further work is also necessary to elucidate the structural basis of inhibition of IP3R activity by Ca2+.

Materials and Methods

Plasmid Constructs.

Substitutions to amino acids D, A, or Q at the desired site/residue in rIP3R3, hIP3R3, and hIP3R1 were generated using Pfu Ultra II Hotstart 2X Master Mix (Agilent Technologies) and appropriate primers obtained from Integrated DNA Technologies (SI Appendix, Table S1). A QuikChange Lightning site–directed mutagenesis kit (Agilent Technologies #210518) was used to introduce the desired substitution in cDNAs encoding the rIP3R3 (NP_037270), hIP3R3 (NP_002215.2), and hIP3R1 (NP_001093422.2) in pDNA3.1 expression plasmid using mutagenic primers. The introduction of desired substitution and coding regions for all of the constructs was confirmed by Sanger sequencing.

Alignment of IP3R Protein Sequences from Various Organisms.

Alignment of IP3R protein sequences from Rattus norvigecus–short IP3R1 (used in Fig. 1C) (P29994.2), IP3R1 (NP_001257525.1) (used in SI Appendix, Fig. S1), IP3R2 (NP_112308.1), and IP3R3 (NP_037270.2); Homo sapiens–IP3R1 (NP_001093422.2), IP3R2 (NP_002214.2), IP3R3 (NP_002215.2), RyR1 (NP_000531.2), RyR2 (NP_001026.2), and RyR3 (NP_001027.3); Capsaspora owczarzaki–IP3RA (XP_004347577.1); Caenorhabditis elegans–IP3R1 (NP_001023170.1); Drosophila melanogaster–IP3R (NP_730941.1); Danio rerio–IP3R1 (XP_021335554.1); Gallus gallus–IP3R1 (NP_001167530.1); Mus musculus–IP3R1 (NP_034715.3); Bos taurus–IP3R1 (NP_777266.1); Canis familiaris–IP3R1 (XP_005632286.1); Macaca mulatta–IP3R1 (NP_034715.3); and Pan troglodytes–IP3R1 (XP_009443057.1) were generated using GeneDoc.

Cell Culture, Transfection, and Generation of Stable Cell Lines.

DT40-3KO, chicken B lymphocyte cells engineered through homologous recombination for the deletion of all of the three-native endogenous IP3R isoforms (70), were cultured in RPMI 1640 media supplemented with 1% chicken serum, 10% fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin in an incubator set to 39 °C with 5% CO2. Transfections in DT40-3KO were performed as previously described (71). In brief, 5 million cells were washed with phosphate-buffered saline (PBS) and electroporated with 4 to 6 μg of appropriate plasmid construct using an Amaxa cell nucleofector (Lonza Laboratories) and nucleofection reagent (362.88 mM ATP-disodium salt, 590.26 mM MgCl2 6.H2O, 146.97 mM KH2PO4, 23.81 mM NaHCO3, and 3.7 mM glucose at pH 7.4). Following transfection, the cells were allowed to recover for 24 h and were subsequently transferred into 96-well plates containing media supplemented with 2 mg/mL G418. Next, 10 to 14 d after transfection, clones expressing the desired construct were expanded and subsequently screened by western blotting. Cell lines stably expressing the construct were used in further experiments.

HEK-3KO and HEK293 cells engineered in our laboratory using CRISPR-Cas technology for the deletion of all of the three-native endogenous IP3R isoforms (19) were cultured in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin in an incubator set to 37 °C with 5% CO2. Transfections of the appropriate plasmid construct were performed using a previously described protocol (19). In brief, 1 million cells were washed with PBS and electroporated with 5 to 10 μg appropriate plasmid using Amaxa cell nucleofector kit T (Lonza Laboratories). Cells were allowed to recover for 48 h, and subsequently subcultured into new 10 cm2 plates containing media supplemented with 1.5 to 2 mg/mL G418. Following 7 d of selection, individual colonies of cells were picked and transferred to new 24-well plates containing media supplemented with 1.5 to 2 mg/mL G418. Clonal lines were expanded and those expressing the desired constructs were confirmed by western blotting (18). All of the experiments using HEK cell lines were approved by the University of Rochester Institutional Biosafety Committee (GNT-Yule-15–007 rev0821).

Western Blotting.

For western blotting, total protein was isolated from indicated control and stable cell lines using membrane-bound extraction buffer (10 mM Tris⋅HCl, 10 mM NaCl, 1 mM ethylene glycol tetraacetic acid (EGTA), 1 mM ethylenediaminetetraacetate, 1 mM NaF, 20 mM Na4P2O7, 2 mM Na3VO4, 1% Triton X-100 (vol/vol), 0.5% sodium deoxycholate [wt/vol], and 10% glycerol) supplemented with protease inhibitors (Roche). Briefly, for protein isolation, following the addition of an appropriate amount of lysis buffer, cells were harvested in 1.5-mL tubes and placed on ice for 30 min. To disrupt the pellet, the tubes were vortexed for 10 s every 10 min and returned on ice. Following incubation on ice, the cell lysates were centrifuged at 13,000 rpm at 4 °C for 10 min. The supernatant was transferred to new labeled tubes. Protein concentration in the lysates was estimated using the Dc protein assay kit (Bio-Rad). Equal amounts of lysates were then subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane. The membranes were incubated with the indicated primary antibodies and appropriate secondary antibodies before imaging with an Odyssey infrared imaging system (LICOR Biosciences). Band intensities were quantified using Image Studio Lite version 5.2 and presented as ratios of IP3R to glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The IP3R1 antibody (#ARC154, Antibody Research Corporation) was used at a 1:1,000 dilution, IP3R3 antibody (#610313, BD Transduction Laboratories) was used at a 1:1,000 dilution, GAPDH (#AM4300, Invitrogen) was used at a 1:75,000 dilution, and secondary goat anti-rabbit (SA535571, Invitrogen) and secondary goat anti-mouse (SA535521, Invitrogen) antibodies were used at a 1:10,000 dilution (67).

Native Blue PAGE Analysis.

HEK-3KO and stable cell lines expressing WT or mutant IP3R1/3 constructs were lysed in CHAPS lysis buffer supplemented with protease inhibitors (Roche). After 15 min on ice, cell lysates were cleared by centrifugation at 13,000 rpm for 10 min at 4 °C. Next, 15 µg cleared lysates were mixed with 4X sample buffer (BN2003, Invitrogen) and 5% G-250 sample additive (BN2004, Invitrogen). Samples were separated at 4 °C on a 3 to 12% Native PAGE Novex (BN2011BX10, Invitrogen) at 150 V for 1.5 h using dark cathode buffer and then at 250 V for 1 h using light cathode buffer (BN2007, Invitrogen) in the inner chamber with anode buffer in the outer chamber. Separated proteins were transferred onto polyvinylidene difluoride membrane using NuPAGE Transfer buffer (NP0006-1, Invitrogen) overnight at 4 °C. Appropriate primary and secondary antibodies were used to detect IP3R1/3 complexes, as indicated for western blotting. Molecular weight markers are based on the mobility of unstained protein standard (LC075, Invitrogen).

Immunocytochemistry and Confocal Microscopy.

HEK-3KO and HEK-3KO cells stably expressing WT and mutant IP3R1/3 constructs were plated on poly-d-lysine (100 μg/mL)-coated coverslips. At roughly 50% confluent, cells were fixed using 4% parafomaldehyde at room temperature for 10 min. Subsequently, coverslips were washed with PBS, and cells were blocked in 10% bovine serum albumin (BSA) for 1 h. Following blocking, cells were incubated in primary antibody against IP3R3 (BD Transduction) and IP3R1 (#ARC154, Antibody Research Corporation) overnight at 4 °C. The following day, the primary antibody was removed, and coverslips were washed 3 times with PBS for 10 min with gentle rocking. Subsequently, the appropriate secondary antibody conjugated to Alexa Fluor 488 (Invitrogen) was incubated for 1 h at room temperature with gentle rocking. After incubation, coverslips were washed with PBS and mounted on slides. After allowing slides to dry, coverslips were sealed onto slides and imaged using confocal microscopy using an Olympus Fluoview 1000 microscope.

Measurement of Cytosolic Ca2+ in Intact Cells.

Population-based Ca2+ imaging in the indicated cell lines was performed as described previously (18, 67). Briefly, adherent cells were plated in 10 cm2 cell culture dishes. Upon attaining 90 to 100% confluency, the cells were loaded with 4 μM Fura-2/AM in cell culture media and incubated at 37 °C in the dark for 1 h. The cells were subsequently washed 3 times with imaging buffer (10 mM HEPES, 1.26 mM Ca2+, 137 mM NaCl, 4.7 mM KCl, 5.5 mM glucose, 1 mM Na2HPO4, and 0.56 mM MgCl2, at pH 7.4). An equal number (300,000 cells/well) of cells were seeded into each well of a black-walled 96-well plate. In contrast, suspended cells were cultured in 75 cm2 flasks, pelleted and washed once with imaging buffer before counting. An equal number (500,000 cells/well) of cells were incubated with 4 μM Fura-2/AM in imaging buffer at room temperature for 1 h with constant rocking. Subsequently, the cells were pelleted and washed twice before being seeded into wells of a black-walled 96-well plate. The cells were centrifuged at 200 × g for 2 min to plate the bottom of the wells and incubated at appropriate temperature for 30 min before imaging. Fura-2/AM imaging was carried out by alternatively exciting the loaded cells between 340 and 380 nm; emission was monitored at 510 nm using FlexStation 3 (Molecular Devices). Data were exported to Microsoft Excel, where the peak response to increasing concentrations of agonist (0.1 to 100 μM CCh or 0.01 to 3 μM trypsin) was determined by calculating the 340/380 ratio and normalizing it to the average of the first 5 data points of the experiment (the basal Ca2+ value). AUC was calculated in GraphPad Prism 8 as increases above baseline that are >10% of the distance from the minimum to the maximum Y using the 5 data points before agonist addition as the baseline. Curve fitting was performed using a logistic dose-response equation in GraphPad Prism 8. Data were reported as triplicates from at least three individual plates.

Single-cell Ca2+ imaging in indicated cell lines was performed as described previously. Briefly, cells were seeded on 15-mm glass coverslips in 12-well plates and left undisturbed overnight. Once attached to the coverslip, the cells were washed with imaging buffer before attachment of the glass coverslip to a Warner perfusion chamber using vacuum grease. Subsequently, the cells were loaded with 2 μM Fura-2/AM for 25 min in the dark at room temperature. Cells were then perfused with imaging buffer and stimulated with indicated concentrations of CCh or trypsin. Ca2+ imaging was performed using an inverted epifluorescence Nikon microscope equipped with a 40× oil immersion objective. Fura-2/AM imaging was carried out by alternatively exciting the loaded cells between 340 nm and 380 nm; emission was monitored at 505 nm. Images were captured every second with an exposure of 20 ms and 4 × 4 binning using a digital camera driven by TILL Photonics software as previously described (18). Image acquisition was performed using TILLvisION software and data were exported to Microsoft Excel, where data were analyzed for change in peak amplitude and percentage of cells with predefined peak amplitudes. Each experiment was repeated at least three times.

Detection and Analysis of Ca2+ Puffs Using TIRFM.

Stable hIP3R1 exogenous WT cells or cells with substitutions at the E2002 site were cultured on 15-mm glass coverslips coated with poly-d-lysine (100 μg/mL) in a 35-mm dish for 36 h. Before imaging, the cells were washed three times with imaging buffer. The cells were subsequently incubated with Cal520-AM (5 µM; AAT Bioquest #21130) and ci-IP3/PM (1 μM, Tocris #6210) in imaging buffer with 0.01% BSA in the dark at room temperature. After 1-h incubation, the cells were washed 3 times with imaging buffer and incubated in imaging buffer containing EGTA-AM (5 μM, Invitrogen #E1219). After 45 min of incubation, the media was replaced with fresh imaging buffer and incubated for an additional 30 min at room temperature to allow for the de-esterification of loaded reagents.

Following loading, the coverslip was mounted in a chamber and imaged using an Olympus IX81 inverted TIRFM equipped with oil-immersion PLAPO OTIRFM 60× objective lens/1.45 numerical aperture. Olympus CellSens Dimensions 2.3 (Build 189987) software was used for imaging. The cells were illuminated using a 488-nm laser to excite Cal-520 and the emitted fluorescence was collected through a band-pass filter by a Hamamatsu ORCA-Fusion complementary metal oxide semiconductor camera. The angle of the excitation beam was adjusted to achieve TIRF with a penetration depth of ∼140 nm. Images were captured from a final field of 86.7 × 86.7 µm (400 × 400 pixels, 1 pixel = 216 nm) at a rate of ∼50 frames/second (binning 2 × 2) by directly streaming into random access memory. To photorelease IP3, ultraviolet (UV) light from a laser was introduced to uniformly illuminate the field of view. Both the intensity of the UV flash and the duration (1 s) for uncaging IP3 were optimized to prevent spontaneous puffs in the absence of loaded ci-IP3. Images were exported as .vsi files. Images, 5 s before and 60 s after flash photolysis of ci-IP3, were captured, as described previously (67).

The .vsi files were converted to .tif files using Fiji and further processed using FLIKA, a Python programming-based tool for image processing (72). From each recording, ∼100 frames (∼2 s) before photolysis of ci-IP3 were averaged to obtain a ratio image stack (F/Fo) and standard definition for each pixel for recording up to 13 s following photolysis. The image stack was Gaussian filtered, and pixels that exceeded a critical value (1.0 for our analysis) were located. The “Detect-puffs” plug-in was used to detect the number of clusters (puff sites), number of events (number of puffs), and the amplitudes and durations of localized Ca2+ signals from individual cells. All of the puffs identified automatically by the algorithm were manually confirmed before analysis. The results from FLIKA were saved to Microsoft Excel and graphs were plotted using GraphPad Prism 8 (73).

Preparation of DT40 Cell Nuclei.

Isolated DT40 nuclei were prepared using homogenization. The homogenization buffer (HB) contained 250 mM sucrose, 150 mM KCl, 3 mM 2-mercaptoethanol (β-ME), 10 mM Tris, 1 mM phenylmethanesulphonylfluoride, pH 7.5, with a complete protease inhibitor tablet (Roche). Cells were washed and resuspended in HB before nuclear isolation using an RZR 2021 homogenizer (Heidolph Instruments) with 15 strokes at 1,200 rpm. A 3-μL aliquot of nuclear suspension was placed in a 3-mL bath solution, which contained 140 mM KCl, 10 mM HEPES, 500 μM BAPTA (1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid), and 246 nM free Ca2+, pH 7.1. Nuclei were allowed to adhere to a plastic culture dish for 10 min before patching.

On-Nuclei Patch-Clamp Experiments.

Single IP3R channel potassium currents (ik) were measured in the on-nucleus patch-clamp configuration using pCLAMP 9 and an Axopatch 200B amplifier (Molecular Devices). Pipette solution contained 140 mM KCl, 10 mM HEPES, 5 mM ATP, with varying concentrations of IP3, BAPTA, and free Ca2+. Free [Ca2+] was calculated using Max Chelator freeware and verified fluorometrically. Traces were consecutive 3-s sweeps recorded at −100 mV, sampled at 20 kHz, and filtered at 5 kHz. A minimum of 15 s of recordings were considered for data analyses. The data are representative of between three and five experiments for each condition presented. Pipette resistances were typically 20 MΩ and seal resistances were >5 GΩ (51).

Data Analysis.

Single-channel openings were detected by half-threshold crossing criteria using the event detection protocol in Clampfit 9. We assumed that the number of channels in any particular nuclear patch is represented by the maximum number of discrete stacked events observed during the experiment. Even at low Po, stacking events were evident. Only patches with one apparent channel were considered for analyses. Probability of opening (Po), unitary current (ik), open and closed times, and burst analyses were calculated using Clampfit 9 and Origin 6 software (OriginLab). All-points current amplitude histograms were generated from the current records and fitted with a normal Gaussian probability distribution function. The coefficient of determination (R2) for every fit was >0.95. The Po was calculated using the multimodal distribution for the open and closed current levels. The threshold for an open event was set at 50% of the maximum open current and events shorter than 0.1 ms were ignored. A “burst” was defined as a period of channel opening following a period of no channel activity, which was >5 times the mean closed time (0.2 ms) within a burst. Ca2+ dependency curves were fitted separately for activation and inhibition with the logistic equation:

Y=[(A1A2)/(1+(X/X0)p)]+A2,

where A1 and A2 are asymptotes, X is the concentration of Ca2+, X0 is the half-maximal concentration, and p is the slope related to the Hill coefficient. Equation parameters were estimated using a nonlinear, least-squares algorithm.

Statistical Analysis.

All of the statistical tests were conducted in GraphPad Prism 9 and data are presented as the mean ± SD. Statistical significance was determined using one-way ANOVA with Tukey’s test or the Mann-Whitney U test as indicated in the figure legends.

Supplementary Material

Supplementary File
Supplementary File
Download video file (81.5MB, avi)
Supplementary File
Download video file (73.2MB, avi)

Acknowledgments

The authors wish to thank Dr. Kamil J. Alzayady, Ms. Taylor R. Knebel for generating stable cell lines, and all of the members of the Yule lab, especially Ms. Kai-Ting Huang and Ms. Amanda M. Wahl for their valuable suggestions. The authors wish to thank Dr. Ian Parker and Dr. Jeffrey Lock (both University of California, Irvine) for assistance and advice with FLIKA. This work was supported by National Institutes of Health grant NIH/DE019245, to D.I.Y.; NIH/R01GM132611, to S.K.J.; NIH/R01GM072804 and Welch Foundation research grant AU-2014-20220331, to I.I.S.; and American Heart Association grant 18CDA34110086, to M.R.B.

Footnotes

The authors declare no competing interest.

This article is a PNAS Direct Submission.

See online for related content such as Commentaries.

This article contains supporting information online at https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2209267119/-/DCSupplemental.

Data, Materials, and Software Availability

All of the study data are included in the article and/or SI Appendix.

Change History

September 26, 2022: An equal contribution footnote was omitted due to a production error. The article has been updated to indicate that Vikas Arige, Lara E. Terry, and Larry E. Wagner II contributed equally to the manuscript.

References

  • 1.Berridge M. J., Lipp P., Bootman M. D., The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 11–21 (2000). [DOI] [PubMed] [Google Scholar]
  • 2.Berridge M. J., Lipp P., Bootman M. D., Signal transduction. The calcium entry pas de deux. Science 287, 1604–1605 (2000). [DOI] [PubMed] [Google Scholar]
  • 3.Blondel O., Takeda J., Janssen H., Seino S., Bell G. I., Sequence and functional characterization of a third inositol trisphosphate receptor subtype, IP3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues. J. Biol. Chem. 268, 11356–11363 (1993). [PubMed] [Google Scholar]
  • 4.Furuichi T., et al. , Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400. Nature 342, 32–38 (1989). [DOI] [PubMed] [Google Scholar]
  • 5.Maranto A. R., Primary structure, ligand binding, and localization of the human type 3 inositol 1,4,5-trisphosphate receptor expressed in intestinal epithelium. J. Biol. Chem. 269, 1222–1230 (1994). [PubMed] [Google Scholar]
  • 6.Mignery G. A., Südhof T. C., Takei K., De Camilli P., Putative receptor for inositol 1,4,5-trisphosphate similar to ryanodine receptor. Nature 342, 192–195 (1989). [DOI] [PubMed] [Google Scholar]
  • 7.Südhof T. C., Newton C. L., Archer B. T. III, Ushkaryov Y. A., Mignery G. A., Structure of a novel InsP3 receptor. EMBO J. 10, 3199–3206 (1991). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Iino M., Biphasic Ca2+ dependence of inositol 1,4,5-trisphosphate-induced Ca release in smooth muscle cells of the guinea pig taenia caeci. J. Gen. Physiol. 95, 1103–1122 (1990). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Berridge M. J., The inositol trisphosphate/calcium signaling pathway in health and disease. Physiol. Rev. 96, 1261–1296 (2016). [DOI] [PubMed] [Google Scholar]
  • 10.Yoshikawa F., et al. , Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 271, 18277–18284 (1996). [DOI] [PubMed] [Google Scholar]
  • 11.Lin C. C., Baek K., Lu Z., Apo and InsP3-bound crystal structures of the ligand-binding domain of an InsP3 receptor. Nat. Struct. Mol. Biol. 18, 1172–1174 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Seo M. D., et al. , Structural and functional conservation of key domains in InsP3 and ryanodine receptors. Nature 483, 108–112 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Fan G., et al. , Gating machinery of InsP3R channels revealed by electron cryomicroscopy. Nature 527, 336–341 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Fan G., et al. , Cryo-EM reveals ligand induced allostery underlying InsP3R channel gating. Cell Res. 28, 1158–1170 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Paknejad N., Hite R. K., Structural basis for the regulation of inositol trisphosphate receptors by Ca2+ and IP3. Nat. Struct. Mol. Biol. 25, 660–668 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Azumaya C. M., Linton E. A., Risener C. J., Nakagawa T., Karakas E., Cryo-EM structure of human type-3 inositol triphosphate receptor reveals the presence of a self-binding peptide that acts as an antagonist. J. Biol. Chem. 295, 1743–1753 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ando H., Hirose M., Mikoshiba K., Aberrant IP3 receptor activities revealed by comprehensive analysis of pathological mutations causing spinocerebellar ataxia 29. Proc. Natl. Acad. Sci. U.S.A. 115, 12259–12264 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Terry L. E., Alzayady K. J., Wahl A. M., Malik S., Yule D. I., Disease-associated mutations in inositol 1,4,5-trisphosphate receptor subunits impair channel function. J. Biol. Chem. 295, 18160–18178 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Alzayady K. J., et al. , Defining the stoichiometry of inositol 1,4,5-trisphosphate binding required to initiate Ca2+ release. Sci. Signal. 9, ra35 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bezprozvanny I., Watras J., Ehrlich B. E., Bell-shaped calcium-response curves of Ins(1,4,5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature 351, 751–754 (1991). [DOI] [PubMed] [Google Scholar]
  • 21.Foskett J. K., White C., Cheung K. H., Mak D. O., Inositol trisphosphate receptor Ca2+ release channels. Physiol. Rev. 87, 593–658 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Finch E. A., Turner T. J., Goldin S. M., Calcium as a coagonist of inositol 1,4,5-trisphosphate-induced calcium release. Science 252, 443–446 (1991). [DOI] [PubMed] [Google Scholar]
  • 23.Kaftan E. J., Ehrlich B. E., Watras J., Inositol 1,4,5-trisphosphate (InsP3) and calcium interact to increase the dynamic range of InsP3 receptor-dependent calcium signaling. J. Gen. Physiol. 110, 529–538 (1997). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Mak D. O., McBride S., Foskett J. K., Inositol 1,4,5-trisphosphate [correction of tris-phosphate] activation of inositol trisphosphate [correction of tris-phosphate] receptor Ca2+ channel by ligand tuning of Ca2+ inhibition. Proc. Natl. Acad. Sci. U.S.A. 95, 15821–15825 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Mak D. O., McBride S., Foskett J. K., Regulation by Ca2+ and inositol 1,4,5-trisphosphate (InsP3) of single recombinant type 3 InsP3 receptor channels. Ca2+ activation uniquely distinguishes types 1 and 3 insp3 receptors. J. Gen. Physiol. 117, 435–446 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Marshall I. C., Taylor C. W., Two calcium-binding sites mediate the interconversion of liver inositol 1,4,5-trisphosphate receptors between three conformational states. Biochem. J. 301, 591–598 (1994). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Taylor C. W., Tovey S. C., IP(3) receptors: Toward understanding their activation. Cold Spring Harb. Perspect. Biol. 2, a004010 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Marchant J. S., Taylor C. W., Cooperative activation of IP3 receptors by sequential binding of IP3 and Ca2+ safeguards against spontaneous activity. Curr. Biol. 7, 510–518 (1997). [DOI] [PubMed] [Google Scholar]
  • 29.Vais H., Foskett J. K., Ullah G., Pearson J. E., Mak D. O., Permeant calcium ion feed-through regulation of single inositol 1,4,5-trisphosphate receptor channel gating. J. Gen. Physiol. 140, 697–716 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Adkins C. E., Taylor C. W., Lateral inhibition of inositol 1,4,5-trisphosphate receptors by cytosolic Ca(2+). Curr. Biol. 9, 1115–1118 (1999). [DOI] [PubMed] [Google Scholar]
  • 31.Lock J. T., Alzayady K. J., Yule D. I., Parker I., All three IP3 receptor isoforms generate Ca2+ puffs that display similar characteristics. Sci. Signal. 11, eaau0344 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mataragka S., Taylor C. W., All three IP3 receptor subtypes generate Ca2+ puffs, the universal building blocks of IP3-evoked Ca2+ signals. J. Cell Sci. 131, jcs220848 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Smith I. F., Wiltgen S. M., Shuai J., Parker I., Ca(2+) puffs originate from preestablished stable clusters of inositol trisphosphate receptors. Sci. Signal. 2, ra77 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Prole D. L., Taylor C. W., Structure and function of IP3 receptors. Cold Spring Harb. Perspect. Biol. 11, a035063 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Sienaert I., et al. , Characterization of a cytosolic and a luminal Ca2+ binding site in the type I inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 271, 27005–27012 (1996). [DOI] [PubMed] [Google Scholar]
  • 36.Sienaert I., et al. , Molecular and functional evidence for multiple Ca2+-binding domains in the type 1 inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 272, 25899–25906 (1997). [DOI] [PubMed] [Google Scholar]
  • 37.Joseph S. K., Brownell S., Khan M. T., Calcium regulation of inositol 1,4,5-trisphosphate receptors. Cell Calcium 38, 539–546 (2005). [DOI] [PubMed] [Google Scholar]
  • 38.Tu H., et al. , Functional and biochemical analysis of the type 1 inositol (1,4,5)-trisphosphate receptor calcium sensor. Biophys. J. 85, 290–299 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Miyakawa T., et al. , Ca(2+)-sensor region of IP(3) receptor controls intracellular Ca(2+) signaling. EMBO J. 20, 1674–1680 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.des Georges A., et al. , Structural basis for gating and activation of RyR1. Cell 167, 145–157.e17 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Xu L., et al. , Ca2+-mediated activation of the skeletal-muscle ryanodine receptor ion channel. J. Biol. Chem. 293, 19501–19509 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Guo W., et al. , The EF-hand Ca2+ binding domain is not required for cytosolic Ca2+ activation of the cardiac ryanodine receptor. J. Biol. Chem. 291, 2150–2160 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Baker M. R., Fan G., Serysheva I. I., Structure of IP3R channel: High-resolution insights from cryo-EM. Curr. Opin. Struct. Biol. 46, 38–47 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Schmitz E. A., Takahashi H., Karakas E., Structural basis for activation and gating of IP3 receptors. Nat. Commun. 13, 1408 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Fan G., et al. , Structural dynamics underlying gating and regulation in IP3R channel. bioRxiv (2022) https://www.biorxiv.org/content/10.1101/2022.05.27.493711v1. Accessed 28 June 2022.
  • 46.Hamada K., Miyatake H., Terauchi A., Mikoshiba K., IP3-mediated gating mechanism of the IP3 receptor revealed by mutagenesis and X-ray crystallography. Proc. Natl. Acad. Sci. U.S.A. 114, 4661–4666 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Ludtke S. J., et al. , Flexible architecture of IP3R1 by cryo-EM. Structure 19, 1192–1199 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Lock J. T., Parker I., IP3 mediated global Ca2+ signals arise through two temporally and spatially distinct modes of Ca2+ release. eLife 9, e55008 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Smith I. F., Parker I., Imaging the quantal substructure of single IP3R channel activity during Ca2+ puffs in intact mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 106, 6404–6409 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Smith I. F., Wiltgen S. M., Parker I., Localization of puff sites adjacent to the plasma membrane: Functional and spatial characterization of Ca2+ signaling in SH-SY5Y cells utilizing membrane-permeant caged IP3. Cell Calcium 45, 65–76 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Wagner L. E. II, Yule D. I., Differential regulation of the InsP3 receptor type-1 and -2 single channel properties by InsP3, Ca2+ and ATP. J. Physiol. 590, 3245–3259 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Betzenhauser M. J., et al. , ATP modulation of Ca2+ release by type-2 and type-3 inositol (1, 4, 5)-triphosphate receptors. Differing ATP sensitivities and molecular determinants of action. J. Biol. Chem. 283, 21579–21587 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Betzenhauser M. J., Wagner L. E. II, Park H. S., Yule D. I., ATP regulation of type-1 inositol 1,4,5-trisphosphate receptor activity does not require walker A-type ATP-binding motifs. J. Biol. Chem. 284, 16156–16163 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Mak D. O., McBride S., Foskett J. K., ATP regulation of type 1 inositol 1,4,5-trisphosphate receptor channel gating by allosteric tuning of Ca(2+) activation. J. Biol. Chem. 274, 22231–22237 (1999). [DOI] [PubMed] [Google Scholar]
  • 55.Jean T., Klee C. B., Calcium modulation of inositol 1,4,5-trisphosphate-induced calcium release from neuroblastoma x glioma hybrid (NG108-15) microsomes. J. Biol. Chem. 261, 16414–16420 (1986). [PubMed] [Google Scholar]
  • 56.Suematsu E., Hirata M., Hashimoto T., Kuriyama H., Inositol 1,4,5-trisphosphate releases Ca2+ from intracellular store sites in skinned single cells of porcine coronary artery. Biochem. Biophys. Res. Commun. 120, 481–485 (1984). [DOI] [PubMed] [Google Scholar]
  • 57.Parker I., Ivorra I., Inhibition by Ca2+ of inositol trisphosphate-mediated Ca2+ liberation: A possible mechanism for oscillatory release of Ca2+. Proc. Natl. Acad. Sci. U.S.A. 87, 260–264 (1990). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Marshall I. C., Taylor C. W., Biphasic effects of cytosolic Ca2+ on Ins(1,4,5)P3-stimulated Ca2+ mobilization in hepatocytes. J. Biol. Chem. 268, 13214–13220 (1993). [PubMed] [Google Scholar]
  • 59.Stehno-Bittel L., Lückhoff A., Clapham D. E., Calcium release from the nucleus by InsP3 receptor channels. Neuron 14, 163–167 (1995). [DOI] [PubMed] [Google Scholar]
  • 60.Boehning D., Joseph S. K., Mak D. O., Foskett J. K., Single-channel recordings of recombinant inositol trisphosphate receptors in mammalian nuclear envelope. Biophys. J. 81, 117–124 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Mignery G. A., Johnston P. A., Südhof T. C., Mechanism of Ca2+ inhibition of inositol 1,4,5-trisphosphate (InsP3) binding to the cerebellar InsP3 receptor. J. Biol. Chem. 267, 7450–7455 (1992). [PubMed] [Google Scholar]
  • 62.Alzayady K. J., et al. , Tracing the evolutionary history of inositol, 1, 4, 5-trisphosphate receptor: Insights from analyses of Capsaspora owczarzaki Ca2+ release channel orthologs. Mol. Biol. Evol. 32, 2236–2253 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Joshi R., Venkatesh K., Srinivas R., Nair S., Hasan G., Genetic dissection of itpr gene function reveals a vital requirement in aminergic cells of Drosophila larvae. Genetics 166, 225–236 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Srikanth S., et al. , Functional properties of the Drosophila melanogaster inositol 1,4,5-trisphosphate receptor mutants. Biophys. J. 86, 3634–3646 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Bootman M. D., Berridge M. J., Lipp P., Cooking with calcium: The recipes for composing global signals from elementary events. Cell 91, 367–373 (1997). [DOI] [PubMed] [Google Scholar]
  • 66.Thillaiappan N. B., Smith H. A., Atakpa-Adaji P., Taylor C. W., KRAP tethers IP3 receptors to actin and licenses them to evoke cytosolic Ca2+ signals. Nat. Commun. 12, 4514 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Arige V., et al. , CREB regulates the expression of type 1 inositol 1,4,5-trisphosphate receptors. J. Cell Sci. 134, jcs258875 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Thillaiappan N. B., Chavda A. P., Tovey S. C., Prole D. L., Taylor C. W., Ca2+ signals initiate at immobile IP3 receptors adjacent to ER-plasma membrane junctions. Nat. Commun. 8, 1505 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Iwai M., Michikawa T., Bosanac I., Ikura M., Mikoshiba K., Molecular basis of the isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors. J. Biol. Chem. 282, 12755–12764 (2007). [DOI] [PubMed] [Google Scholar]
  • 70.Sugawara H., Kurosaki M., Takata M., Kurosaki T., Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor. EMBO J. 16, 3078–3088 (1997). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Alzayady K. J., Chandrasekhar R., Yule D. I., Fragmented inositol 1,4,5-trisphosphate receptors retain tetrameric architecture and form functional Ca2+ release channels. J. Biol. Chem. 288, 11122–11134 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Ellefsen K. L., Settle B., Parker I., Smith I. F., An algorithm for automated detection, localization and measurement of local calcium signals from camera-based imaging. Cell Calcium 56, 147–156 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Arige V., Emrich S. M., Yoast R. E., Trebak M., Yule D. I., A protocol for detecting elemental calcium signals (Ca2+ puffs) in mammalian cells using total internal reflection fluorescence microscopy. STAR Protoc 2, 100618 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary File
Supplementary File
Download video file (81.5MB, avi)
Supplementary File
Download video file (73.2MB, avi)

Data Availability Statement

All of the study data are included in the article and/or SI Appendix.


Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES